You Searched For: 5-Phenyl-1H-pyrazolo[3,4-c]pyridazin-3-ylamine


34 901  results were found

SearchResultCount:"34901"

Sort Results

List View Easy View (new)

Rate These Search Results

Supplier: Apollo Scientific
Description: 5-Phenyl-1H-pyrazolo[3,4-c]pyridazin-3-ylamine

Supplier: Apollo Scientific
Description: 1-Methyl-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine

All-day power. Every day durability

Work quickly with the compact, powerful M510 and M611 Label Printers, delivering high-volume, high-quality labels via Bluetooth or Wi-Fi

Learn more

Meet the M510 & M611 Label printers

Supplier: Apollo Scientific
Description: 4,6-Dimethyl-1H-pyrazolo[3,4-b]pyridin-3-ylamine

Supplier: Apollo Scientific
Description: 1-Methyl-1H-pyrazolo[3,4-b]pyridin-3-ylamine 97%

Supplier: Apollo Scientific
Description: 1H-Pyrazolo[3,4-d]pyrimidin-4-amine 95%

Supplier: Apollo Scientific
Description: MAPK/ERK Signalling Pathway

Catalog Number: (APOSOR2650T-250MG)
Supplier: Apollo Scientific
Description: Chemiluminescent with antifilarial & affinity for the adenosine receptor.
UOM: 1 * 250 mg


Supplier: Apollo Scientific
Description: MAPK/ERK Signalling Pathway

Supplier: Thermo Scientific
Description: Apixaban

Supplier: Cayman Chemical
Description: Apixaban is an orally bioavailable, selective inhibitor of both free and prothrombinase-bound factor Xa (K<sub>i</sub>s = 0.8 nM).

Supplier: ENZO LIFE SCIENCES
Description: Highly potent, ATP-competitive, and specific mTOR kinase inhibitor. Antiproliferative.

New Product

Supplier: Apollo Scientific
Description: 6-Methyl-4-(trifluoromethyl)-1,6-dihydropyrazolo[3,4-c]pyrazol-3-ylamine 95+%

Supplier: Cayman Chemical
Description: WYE-125132 is an ATP-competitive inhibitor of mTOR (IC<sub>50</sub> = 0,19 nM) that inhibits signaling through both mTORC1 and mTORC2. It is selective for mTOR over phosphatidylinositol 3-kinase isoforms. WYE-125132 is effective against mTORC1 and mTORC2 in diverse cancer models, both <i>in vitro</i> and <i>in vivo</i>. Oral administration of WYE-125132 alone blocks mTOR signaling and prevents tumor growth in breast, lung, renal, and glioma cancer xenografts in mice, while combination therapy with the VEGF-inhibitor bevacizumab causes complete regression of A498 renal carcinoma tumors. In addition to its applications in cancer, WYE-125132 has been used to delineate novel aspects of mTOR signaling.

Catalog Number: (APOSOR30697-1G)
Supplier: Apollo Scientific
Description: 1H-Pyrazolo[3,4-c]pyridine 95+%
UOM: 1 * 1 g


Supplier: Apollo Scientific
Description: 1H-Pyrazolo[3,4-b]pyridin-3-amine

Catalog Number: (APOSOR902364-1G)
Supplier: Apollo Scientific
Description: 1H-Pyrazolo[3,4-b]pyrazin-3-amine
UOM: 1 * 1 g


Inquire for Price
Stock for this item is limited, but may be available in a warehouse close to you. Please make sure that you are logged in to the site so that available stock can be displayed. If the call is still displayed and you need assistance, please call us at +43 1 97002 - 0.
Stock for this item is limited, but may be available in a warehouse close to you. Please make sure that you are logged in to the site so that available stock can be displayed. If the call is still displayed and you need assistance, please call us at +43 1 97002 - 0.
Dual use goods can only be delivered within the European Union.
Dual use goods can only be delivered within the European Union.
This product has been blocked by your organization. Please contact your purchasing department for more information.
The original product is no longer available. The replacement shown is available.
This product is no longer available. Alternatives may be available by searching with the VWR Catalog Number listed above. If you need further assistance, please call VWR Customer Service at +43 1 97002 - 0.
1 - 16 of 34 901
no targeter for Bottom